Clinical Trial Update: Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis

View source ↗

Summary

This document reports the withdrawal of a post-marketing surveillance trial evaluating the safety and efficacy of Enbrel (etanercept) in pediatric patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Pediatric Psoriasis | Status: WITHDRAWN